On December 23, 2024, Spectral AI, Inc. announced that it received a 'moot' letter from Nasdaq. This letter confirmed that the company has regained compliance with all applicable listing standards for its continued listing on the Nasdaq Capital Market.
The confirmation means that a further hearing regarding the company’s compliance is no longer necessary. This resolution addresses a significant concern for investors regarding the company's listing status.
Dr. Michael DiMaio, Chairman of Spectral AI’s Board of Directors, expressed satisfaction with the confirmation, highlighting the team's commitment to meeting Nasdaq's compliance standards. This provides stability as the company progresses towards its FDA submission.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.